Does EVEROLIMUS Cause Pulmonary hypertension? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Pulmonary hypertension have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.1% of all adverse event reports for EVEROLIMUS.
36
Reports of Pulmonary hypertension with EVEROLIMUS
0.1%
of all EVEROLIMUS reports
10
Deaths
21
Hospitalizations
How Dangerous Is Pulmonary hypertension From EVEROLIMUS?
Of the 36 reports, 10 (27.8%) resulted in death, 21 (58.3%) required hospitalization, and 1 (2.8%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
Yes, Pulmonary hypertension is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which EVEROLIMUS Alternatives Have Lower Pulmonary hypertension Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE